A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
University of California, Davis
University of California, Davis
University of Michigan Rogel Cancer Center
Rutgers, The State University of New Jersey
UMC Utrecht
Aveni Foundation
University of Virginia
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
Duke University
Washington University School of Medicine
University of Florida
University of Florida
Essen Biotech
Essen Biotech
Leiden University Medical Center
Hospital Moinhos de Vento
Columbia University
Ottawa Hospital Research Institute
Memorial Sloan Kettering Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Colorado, Denver
Alliance for Clinical Trials in Oncology
Centre Paul Strauss
Unity Health Toronto
Mälardalen University
University of Maryland, Baltimore
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center
University of Nebraska
Dana-Farber Cancer Institute
University of Michigan Rogel Cancer Center
Kidney Cancer Research Bureau
HealthPartners Institute
Medstar Health Research Institute
University of Kansas Medical Center
Medical College of Wisconsin
Fred Hutchinson Cancer Center
Swiss Cancer Institute
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
University of Oklahoma
Wake Forest University Health Sciences
Centre Hospitalier Universitaire de Besancon
City of Hope Medical Center
University of Southern California
University of California, Davis
European Institute of Oncology
Memorial Sloan Kettering Cancer Center
Centre Hospitalier Universitaire de Nīmes